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Abstract
Background/Aims: The purpose of this study was to investigate the implications of protein 
kinase C-epsilon (PKCε), Extracellular Signal-regulated Kinase 1/2 (ERK1/2) and mitochondrial 
permeability transition pore (mPTP) in myocardial protection induced by morphine 
postconditioning (MpostC). Methods: The isolated rat hearts were randomly assigned into 
one of eight groups. Hearts in time control (TC) group were constantly perfused for 105min. 
Hearts in ischemia-reperfusion (I/R) group were subjected to 45 min of ischemia followed by 
1 h of reperfusion. MpostC was induced by 10 min of morphine administration at the onset of 
reperfusion. εV1-2 (an inhibitor of PKCε) and PD (an inhibitor of ERK1/2) was administered with 
or without morphine during the first 10 min of reperfusion following the 45 min of ischemia. 
I/R injury was assessed by functional parameters, creatine kinase-MB (CK-MB) release and 
infarct size (IS/AAR). Additional hearts were excised at 20 min following reperfusion to 
detect the membrane-specific translocation of PKCε, ERK1/2 phosphorylation, mitochondrial 
permeability transition (MPT) and cytochrome C (Cyt-c) release. Results: MpostC markedly 
reduced infarct size (IS/AAR), CK-MB release, and improved cardiac function recovery. However, 
these protective effects were partly abolished in the presence of εV1-2 or PD. Compared to TC 
group, the membrane translocation of PKCε, ERK1/2 phosphorylation, mPTP opening, and 
Cyt-c release were significantly increased in I/R hearts. MpostC further increased the membrane 
translocation of PKCε and ERK1/2 phosphorylation, and significantly inhibited mPTP opening 
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and Cyt-c release. However, those protective effects induced by MpostC were abolished by 
εV1-2 or PD, which, used alone, showed no influence on reperfusion injury. Conclusions: These 
findings suggest that MpostC protects isolated rat hearts against ischemia-reperfusion injury 
via activating PKCε-ERK1/2 pathway and inhibiting mPTP opening.
Introduction
We previously demonstrated that administration of morphine immediately at the onset of 
reperfusion, namely morphine postconditioning (MpostC), reduced the infarct size to an extent 
similar to morphine preconditioning (MPC) [1], and our recent study further showed that the 
cardioprotection induced by MpostC is via inhibiting JNK/p38 MAPK and mitochondrial permeability transition pores (mPTP) signaling pathway [2]. Because anisomycin (an activator of JNK/p38 kinases) only partly reversed the infarct-sparing effect of MpostC, it 
implies that there might be alternative mechanisms involved in MpostC.
One family of signaling proteins commonly linked to the modulation of ischemia–reperfusion 
injury is protein kinase C (PKC), particularly the PKC isozyme PKCε [3, 4]. Previous research 
demonstrated that membrane translocation of PKCε was critical to triggering cardioprotective effects in both ischemic preconditioning (preC) [5] and ischemic postconditioning (postC) [6, 
7]. Furthermore, PKCε activation is also involved in the cardioprotective effect produced by opioid receptor agonist induced preC [8, 9]. Is PKCε also involved in opioid receptor agonist 
induced posC? And if it is, what is the potential downstream target of PKCε activation? All these questions are still unclear.
Extracellular signal-regulated kinase (ERK) 1/2 is one important component of reperfusion 
injury survival kinases (RISK), which are activated at the time of reperfusion and afforded 
opportunity for protecting the heart against lethal reperfusion-induced injury [10]. Evidence 
shows that the activation of ERK1/2 was implicated in both preC [11] and postC [12], indicating 
that preC and postC possibly recruit a common signal pathway during myocardial reperfusion. 
Furthermore, recent studies suggested that the phosphorylation of ERK1/2 was involved in opioid 
receptor agonist induced postC [13, 14], but the exact mechanism through which ERK1/2 was 
activated in opioid-induced postC remains unclear.It is well known that mPTP plays a paramount role in reperfusion injury [15], and studies 
showed that both ischemic and anesthetic induced postC afford cardioprotection via inhibiting mPTP opening by activation of ERK1/2 [16, 17]. Therefore, the objective of the present study 
was to determine whether the RISK pathway (PKCε and ERK1/2) and mPTP were involved in MpostC-induced cardioprotection.
Materials and MethodsAll experimental procedures and protocols used in this investigation were reviewed and approved by 
the Institutional Animal Care and Use Committee of the Affiliated Hospital of Qingdao University and were performed in accordance with the Guide for the Care and Use of Laboratory Animals from the Institute of Laboratory Animals Resources.
Isolated Heart Preparation
Preparation of isolated rat hearts was performed as we previously described [1]. In brief, male Sprague-
Dawley rats weighing 180–200 g were anesthetized with an intraperitoneal injection of 40 mg/kg sodium 
pentobarbital and decapitated. The hearts were rapidly excised, mounted on a Langendorff apparatus, and 
retrogradely perfused at 100 cm H2O with Krebs-Ringer’s solution (115 mM NaCl, 5 mM KCl, 1.2 mM MgSO4, 
1.2 mM KH2PO4, 1.25 mM CaCl2, 25 mM NaHCO3, and 11 mM glucose) gassed with 95% O2-5% CO2 (pH 7.4, 
temperature 37°C). A fluid-filled latex balloon was inserted through left atrium and passed through the mitral 
orifice into the left ventricle. The balloon was connected to a pressure transducer for continuous monitoring 
of left ventricular developed pressure (LVDP), left ventricular end-diastolic pressure (LVEDP) and heart rate 
© 2016 The Author(s)
Published by S. Karger AG, Basel
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(HR) via PowerLab Systems (PowerLab/8sp, AD Instruments, Australia). At first, the heart was ongoing a 15-min stabilization period, and any heart showing intractable arrhythmia or low left ventricular systolic pressure 
(LVSP) < 50 mmHg was excluded from the study.
Experimental Protocols
All hearts were randomly divided into 1 of 8 groups (n = 8, respectively)v(Fig. 1). ①TC group (time 
control): hearts were constantly perfused with K-R buffer for 105 min; ②I/R group (ischemic control): 
hearts were subjected to 45 min of ischemia followed by 1 h of reperfusion; ③MpostC group (morphine, 3.0 
μmol/L); ④MpostC +εV1-2 group: εV1-2 (PKCε inhibitor), 1.0 μmol/L]; ⑤εV1-2 group; ⑥MpostC +PD group: PD (ERK1/2 inhibitor), 20.0 μmol/L; ⑦PD group; ⑧DMSO group (DMSO, 0.02%). After a 45-min ischemia 
period, hearts in group ⑤, ⑦ and ⑧ were administered morphine (3.0 μmol/L), εV1-2, PD and DMSO 
respectively for 10 min at the onset of reperfusion, and then were followed by 50 min reperfusion, while 
hearts in group ④ and ⑥ were treated with morphine (3.0 μmol/L) co-administered with εV1-2 and PD for 10 min at the onset of reperfusion respectively, and then were followed by 50 min reperfusion. Additional hearts were used 20 min after reperfusion of the above 8 groups (n = 5, respectively) to detect the membrane-
specific translocation of PKCε (group①—⑤), ERK1/2 phosphorylation, mitochondrial permeability transition (MPT) and cytosolic levels of cytochrome C (Cyt-c) (group①—⑧). The concentrations used in 
this study were based on previous studies [1, 17, 18], and all reagents, unless specified, were obtained from 
Sigma Chemicals (St. Louis, MO).
Determination of myocardial infarct size and myocardial injuryMyocardial infarct size and myocardial injury were measured as we previously described [1]. In short, infarct size was determined by 2, 3, 5-triphenyltetrazolium chloride (TTC) staining method, and infarct size was determined by dividing the total necrotic area of the left ventricle by the total left ventricular slice area 
(IS/AAR). In addition, the release of CK-MB, expressed as U/h/g, was measured by collecting total coronary 
effluent over the 60 min reperfusion period.
Cytosolic and particulate fraction preparation
Cytosolic protein contents and particulate fraction of the myocardium were prepared in accordance with Gao 
et al. [19]. In brief, frozen samples were homogenized at 0°C-4°C in buffer A consisting of 50 mM Tris-Cl, pH 7.5, 
2 mM EDTA, 2 mM EGTA, 1mM dithiothreitol, and inhibitors for protease and phosphatase. These homogenates 
were centrifuged at 300,000 g for 30 minutes at 4°C in an Optima TLX Ultracentrifuge (Beckman Coulter CO.) 
to yield the cytosolic fraction. Resuspended in buffer B (buffer A + 0.5% Nonidet P-40), the crude membrane 
fraction pellet was sonicated and then centrifuged at 300,000 g for 30 minutes at 4°C. The final supernatant was the 
Fig. 1. Scheme of treatment protocols. 
Heats in TC group were constantly perfused with K-R buffer for 105min. 
Hearts in other groups were subject to 45 min ischemia followed by 60 min reperfusion. MpostC was performed by a 10-min perfusion of morphine at 
the onset of reperfusion. εV1-2 and PD was administered with or without mor-phine. Left ventricular tissue samples 
were collected for Western Blotting and spectrophotometric analysis at 20 min following reperfusion. Infarct size and 
CK-MB release were measured at the end of reperfusion. TC, time control; I/R, ischemia reperfusion; MpostC, morphi-ne postcondtioning; PD, ERK1/2 inhibi-
tor; DMSO, dimethyl sulphoxide.
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particulate fraction. The protein concentrations were measured by BCA protein assay kit (Pierce, Rockford, IL) and using bovine serum albumin standards.
Western blotting analysis
40μg of protein from each sample was loaded per lane in 10% SDS polyacrylamide gel electrophoresis (PAGE) gels. After being electrotransferred and blocked, the membrane was incubated overnight at 4°C with 
the primary antibody anti-PKCε (1:1000) and a secondary antibody conjugated with horseradish peroxidase 
(1:1000; Santa Cruz Biotechnology Inc., CA, USA) at room temperature. After washing three times, bands were 
detected using ECL-plus reagents (Pharmacia Biotech, Piscataway, NJ). To check the slight variation in protein 
loading between samples, western blot for β-actin was performed as an internal control. The relative optical 
density of bands from each sample was normalized against that of β-actin, and results were presented as a percentage of TC.
To determine the changes of ERK1/2 phosphorylation, 80μg of protein from the whole tissue 
homogenate was loaded per lane in 8% SDS-PAGE gel. The primary antibodies specific to ERK1/2 and phosphorylated ERK1/2Thr-202/ Tyro-204 were purchased from Santa Cruz (1:1000; Santa Cruz Biotechnology Inc., 
CA, USA). The phosphorylation levels of ERK1/2 were expressed as a percentage of ERK1/2.
Detection of mPTP opening and Cyt - c release in cytosolThe preparation of mitochondria and cytosolic fractions and detection of mPTP opening and Cyt - c was performed as we previously described [2]. Left ventricular myocardium was homogenized in cold isolation medium, and cell debris was pelleted by centrifuging the homogenate twice for 5 min at 600 g; the supernatant was centrifuged for 10 min at 10 000 g at 4°C, then the pellet was resuspended in isolation 
buffer and washed twice by recentrifugation at 10 000 g for 10 min at 4°C; the final pellet was resuspended in isolation buffer as a mitochondrial preparation, and the supernatant was centrifuged for 1 h at 100,000 g to obtain cytosolic fraction. The protein concentrations were measured as above described.
Isolated mitochondria (1 mg protein) were resuspended in swelling buffer to a final volume of 2 ml, 
and incubated at 25°C for 2 min. mPTP opening, induced by 2, 20 and 200 μmol/L CaCl2, was followed by Mitochondrial permeability transition (MPT), and resulted in mitochondrial swelling, and was measured by 
spectrophotometry (DU800; Beckman Coulter, USA) as a reduction in the optical density at 540nm (OD540) 
during 5 min (ΔOD/min).
After SDS-PAGE, cytosolic proteins were transferred to a nitrocellulose membrane and incubated 
with anti-Cytochrome c and β-actin antibodies (mouse polyclonal antibodies diluted 1:200, Santa Cruz 
Biotechnology, USA) for 6 hours followed by a peroxidase-conjugated secondary antibody. The signal was detected and measured as ascribed above.
Statistical analysisData are expressed as mean ± SD. Hemodynamic data were analyzed using two-way repeated measures 
analysis of variance for time and treatment effects. If an overall significance was found, comparisons between groups were done for each time point using one-way analysis of variance, followed by Tukey post hoc testing. For other data, one-way analysis of variance with Tukey post hoc testing for multiple comparisons was used, and P < 0.05 (two-tailed) was considered statistically significant. ALL statistical analysis was performed 
with SPSS 19.0 software (SPSS Inc., Chicago, .USA).
Results
Effects on hemodynamicsThe baseline hemodynamics were similar among all experimental groups (P > 0.05), and all variables remained constant in TC group during the experiment (Table 1). Compared to baseline, the cardiac function in the other seven groups demonstrated deterioration at 
10, 30, 60 min of reperfusion, as evidenced by an obvious reduction in CF, HR, and LVDP, 
and a significant increase in LVEDP (P < 0.05). All hemodynamic variables were better in MpostC group than those in I/R group (P < 0.05). However, the functional improvements 
elicited by MpostC were partly reversed by either εV1-2 or PD, both of which did not influence 
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cardiac recovery when used alone (P > 0.05). In addition, DMSO had no effect on cardiac hemodynamics (P > 0.05).
Effects on myocardial infarction and CK-MB release
Compared to I/R group, MpostC markedly reduced IS/AAR (P < 0.05) (Fig. 2A) and 
CK-MB (P < 0.05) (Fig. 2B). However, the protective effects induced by MpostC were partly 
reversed by coadministration of either εV1-2 or PD (P < 0.05), both of which, when given 
Table 1. Effects of various treat-ments on hemodynamic parame-
ters. Baseline, 15 min after stabili-zation; I/R, ischemia reperfusion; 
HR, heart rate; LVDP, left ventricu-
lar developed pressure; LVEDP, left ventricular end-diastolic pressure; MpostC, morphine postconditi-
oning; εV1-2, PKCε inhibitor; PD, 
ERK1/2 inhibitor; DMSO, dimethyl sulphoxide. Data were presented as 
mean ± SD (n = 8/group). * P < 0.05 vs. baseline (intragroup compari-son), † P < 0.05 vs. respective value in TC group (intergroup compari-son), § P < 0.05 vs. respective value in I/R group (intergroup compari-son)
Fig. 2. Effects of various treatments on 
infarct size (IS/AAR) (A) and CK-MB re-
lease (B). Infarct size was expressed as a 
percentage of the area at risk (IS/AAR). TC group was not included because no 
obvious necrotic area was identified. TC, time control; I/R, ischemia reperfusion; 
MpostC, morphine (3.0 μmol/L); εV1-2, 1.0 
μmol/L; PD, 20 μmol/L; DMSO, 0.02%. 
Values were presented as mean ± SD (n = 8/group). *P < 0.05 vs. TC, † P < 0.05 vs. I/R, § P < 0.05 vs. MpostC.
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alone, showed no influence on the aspects (P = 0.12, P = 0.10; P = 0.10, P = 0.08). DMSO had 
no effect on IS/AAR and CK-MB release (P = 0.25, P = 0.20).
Effects on membrane-specific translocation of PKCε
Compared with TC group, the membrane translocation of PKCε from the cytosolic 
fraction to the particulate was significantly increased in I/R group (P < 0.05) (Fig. 3). 
MpostC further enhanced the membrane translocation of PKCε, when compared to hearts in I/R group (P < 0.05). εV1-2, administered alone or together with morphine, significantly 
inhibited membrane translocation of PKCε (P < 0.05) (Fig. 3), suggesting that PKCε activation is involved in MpostC.
Fig. 3. Effects of various treatments on membrane-specific translocation 
of PKCε. The upper panel shows re-presentative membrane and cytoso-
lic PKCε of 5 groups. The densities of 
PKCε were normalized against those 
of β-actin, and the results were ex-pressed as percentage to TC, as shown in the low panel. TC, time control; I/R, ischemia reperfusion; MpostC, mor-
phine (3.0 μmol/L); εV1-2, 1.0 μmol/L. 
Values were presented as mean ± SD (n = 5/group). * P < 0.05 vs. TC, † P < 0.05 vs. I/R, § P < 0.05 vs. MpostC.
Fig. 4. Effects of various treatments on ERK1/2 phosphorylation. The up-
per panel shows representative ERK1/2 
phosphorylation of each of the eight 
groups. The densities of phosphorylated 
ERK1/2 were normalized against total 
ERK1/2 expression, and the results were expressed as percentage to TC 
as shown in the lower panel. TC, time control; I/R, ischemia reperfusion; 
MpostC, morphine (3.0 μmol/L); εV1-
2, 1.0 μmol/L; PD, 20 μmol/L; DMSO, 
0.02%. Values were presented as 
mean ± SD (n = 5/group). * P < 0.05 vs. TC, † P < 0.05 vs. I/R, § P < 0.05 vs. MpostC.
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Effects on ERK1/2 phosphorylation
Compared with TC group, ERK1/2 phosphorylation was significantly increased in I/R 
group (P < 0.05) (Fig. 4). MpostC further enhanced ERK1/2 phosphorylation, when compared to 
hearts in I/R group (P < 0.05). Both εV1-2 and PD, administered alone or together with morphine, 
significantly inhibited ERK1/2 phosphorylation (P < 0.05), suggesting that PKCε plays an important role in inducing ERK1/2 phosphorylation either after I/R or MpostC. DMSO did not 
influence ERK1/2 phosphorylation (P = 0.22).
Effects on Ca2+ induced mPTP opening
When compared with TC group, ∆OD/min in the I/R group was markedly increased (P < 
0.05), while hearts in MpostC group have a lower ∆OD/min than those of I/R group (Fig. 5). 
When co-administered with morphine, either εV1-2 or PD abolished the inhibitory effect on 
∆OD/min observed with MpostC (P < 0.05). In addition, εV1-2, PD or DMSO had no influence 
on the ∆OD/min when used alone (P = 0.16, P = 0.25, P = 0.30).
Effects on cytosolic levels of Cyt–c
The cytosolic level of Cyt-c was significantly increased in I/R group, when compared to TC group (P < 0.05) (Fig. 6). Relative to I/R group, MpostC significantly reduced the level of Cyt-c in cytosol (P < 0.05). Both εV1-2 and PD abolished the inhibitory effect of MpostC on 
Cyt–c release (P < 0.05), while εV1-2, PD or DMSO had no influence on cytosolic levels of Cyt-c (P = 0.11, P = 0.20, P = 0.33).
Fig. 5. Effects of various treatments on mitochondrial permeability tran-sition (MPT). MPT was expressed as 
a reduction in OD540 during 5 min 
(ΔOD/min). TC, time control; I/R, ischemia reperfusion; MpostC, mor-
phine (3.0 μmol/L); εV1-2, 1.0 μmol/L; 
PD, 20 μmol/L; DMSO, 0.02%. Values 
were presented as mean ± SD (n = 5/group). * P < 0.05 vs. TC, † P < 0.05 vs. I/R, § P < 0.05 vs. MpostC.
Fig. 6. Effects of various treatments on Cytochrome C (Cyt-c) in cytosol. The upper panel shows represen-tative Cyt-c levels of 5 groups. The densities of Cyt-c were normalized 
against those of β-actin, and the re-sults were expressed as percentage to TC as shown in the low panel. TC, time control; I/R, ischemia reperfusi-
on; MpostC, morphine (3.0 μmol/L); 
εV1-2, 1.0 μmol/L; PD, 20 μmol/L; 
DMSO, 0.02%. Values were presen-
ted as mean ± SD (n = 5/group). * P < 0.05 vs. TC, † P < 0.05 vs. I/R, § P < 0.05 vs. MpostC.
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Discussion
In the present study, we investigated the roles of PKCε, ERK1/2 and mPTP in morphine-
induced postC in the isolated rat heart. The new findings were summarized as follows: (1) 
Because εV1-2 and PD partly abolished the cardioprotection of MpostC, it indicated that both 
PKCε and ERK1/2 are involved in MpostC; (2) Subsequent western blot analysis showed that 
MpostC significantly enhanced PKCε membrane translocation and ERK1/2 phosphorylation. 
In addition, these effects were completely blocked by εV1-2, demonstrating that PKCε might 
be an upstream regulator of ERK1/2. (3) Because PD abolished the inhibitory effect on mPTP opening induced by MpostC, suggesting that such protective effect occurs downstream of ERK1/2 activation. Taken together, the present study showed that MpostC protects against 
reperfusion injury via activating PKCε-ERK1/2-mPTP signaling pathway in isolated rat heart.
The activation of PKC is associated with membrane translocation from the cytosol to the 
particulate fraction of the cell [20], and the activation of PKC, in particular, the PKCε isoform, is pivotal in protecting hearts from ischemia reperfusion injury in preC [3]. Furthermore, studies 
suggested that the infarct-sparing effect of ischemic postC is also dependent on the activation of 
PKCε [6, 19]. Therefore, it seems that preC and postC might share some common pathways to 
protect the heart. Zhang and colleagues showed that remifentanil (an opioid analgesic) mimics cardioprotective effect of ischemic preC via PKC activation [21], while the present study 
provided new evidence that the activation of PKC isoform ε is involved in cardiprotection induced by MpostC.
As an important reperfusion injury salvage kinase (RISK), ERK1/2 plays a pivotal role in 
protecting the heart against ischemia reperfusion injury [10, 22], and studies indicated that the 
protective effects of ischemic and anesthetic postC were conferred by ERK1/2 phosphorylation 
[12, 17]. The present study demonstrated that MpostC protected the hearts against reperfusion 
injury through the phosphorylation of ERK1/2, which is consistent with what Ha et al. [13] and 
Kim et al. [14] suggested using remifentanil postC (an exogenous opioid receptor agonist) strategy. 
However, the mechanisms through which ERK1/2 is activated in postconditioned hearts are still 
unclear. The activation of ERK1/2 is regulated by phosphorylation, and this process was shown 
to be PKC-dependent [23]. Moreover, the PKCε-ERK1/2 signaling cascade was shown to be involved in the protective effect of ischemic preC [11, 24], while the present study further 
verified that ERK1/2 phosphorylation is also regulated by PKCε translocation in MpostC, which offers new insights into the post-receptor signaling pathway in opioid receptor agonist-
induced postC.
On the contrary, it was demonstrated that ERK1/2-dependent activation of PKCε was 
involved in desflurane preC induced protective effects in in vivo rat hearts [25]. Furthermore, 
Penna et al. suggested that acid postC protected against myocardial I/R injury by activating 
ERK1/2-PKCε pathways in isolated rat hearts [26]. Though the differences of treatments 
(preC versus postC), dugs (morphine versus desflurane or acid perfusion), and animal models 
(in vitro versus in vivo) might account for the inconsistent observations, we cannot exclude the 
presumption that there might be an ERK1/2-PKCε positive feedback regulation in postC, 
namely, that PKCε dependently phosphorylates ERK1/2 while the phosphorylated ERK1/2 in 
turn activates PKCε because it has been shown that ERK 1/2 is both upstream and downstream 
of PKC in preC [27]. More evidence is necessary to further verify this presumption.It is well known that mPTP plays a paramount role in reperfusion injury [15, 28, 29], 
and it has been strongly implicated as an end-effector in postC [27, 30]. We recently verified MpostC prevents mPTP opening via inhibiting JNK/p38 MAPK activation in isolated rat heats [2]. Given that anisomycin only partly reversed the infarct-sparing effect of MpostC, it implies 
that there might be alternative mechanisms involved in MpostC. Using the same experimental 
model, the present findings indicated that activating PKCε–ERK1/2 pathway is an alternative mechanism involved in inhibition of mPTP opening induced by MpostC, which is consistent with what Yao et al. founded using anesthetic-induced postC strategy [17].
So far, the specific mechanism through which ERK1/2 regulates mPTP in myocardium is 
still unknown. It has been demonstrated that PKCε and ERK1/2 interact and form functional 
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signaling modules in mitochondria [24], furthermore, studies verified that the active PKCɛ, 
designated PKCɛ1 that is bound to the mitochondrial inner membrane, phosphorylates mKATP and causes it to open [31]; the resulting increase in K+ influx with attendant matrix alkalinization then causes increased reactive oxygen species (ROS) production by complex I of the respiratory chain, and the ROS activates a second pool of PKCɛ, designated PKCɛ2, which inhibits MPT in a phosphorylation-dependent reaction [32].The current results must be interpreted within the following limitations. (1) In contrast to an in vivo model, isolated hearts have a limited long-term biologic stability and may undergo short confounding ischemic periods during the surgical procedure, which could potentially affect our observation. (2) There is not general agreement concerning the optimal time of reperfusion necessary to assess myocardial infarct size on isolated perfused heart model. In isolated mice heart, Rossello et al. reported that infarct size progressively increases with the duration of both ischemia and reperfusion, and concluded that 180-min reperfusion might be optimal [33]. While in isolated rat heart, Ferrera and colleagues demonstrated that 60-
min reperfusion is sufficient to demark infarct zones with no additional infarction occurring with longer periods of reperfusion [34]. In the present study with 45-min ischemia and 60-min reperfusion protocol in isolated rat heart, we cannot completely rule out the possibility 
that the shorter reperfusion time might be insufficient to wash out LDH and cofactors from 
necrotic cells to influence the effect of TTC staining when compared to 2-3 h. Taken together, it is necessary to be prudent to explain the present results.In conclusion, the present study shows MpostC protects isolated rat hearts against 
ischemia-reperfusion injury via activating PKCε-ERK1/2 pathway and inhibiting mPTP opening, which provides new insights into the post-receptor signal pathways involved in opioid-induced postC in myocardium.
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